Efficacy and Safety of Tirofiban in Clinical Patients With Acute Ischemic Stroke

BACKGROUND: Intravenous thrombolysis and endovascular thrombectomy have been approved for acute ischemic stroke (AIS). However, only a minority of patients received these treatments in China. We aimed to evaluate the efficacy and safety of tirofiban in patients with AIS who were not undergoing early...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Bin, Ma, Teng, Liu, Zhendong, Wu, Yiqun, Tan, Weiwei, Sun, Shaoyang, Li, Xuemei, Shao, Changyan, Tang, Duyong, Sun, Jinping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860815/
https://www.ncbi.nlm.nih.gov/pubmed/35211073
http://dx.doi.org/10.3389/fneur.2021.785836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860815/
https://www.ncbi.nlm.nih.gov/pubmed/35211073
http://dx.doi.org/10.3389/fneur.2021.785836

Ejemplares similares